New Insights into the Association Between Non-alcoholic Fatty Liver Disease and Atherosclerosis

Overview

Journal Ann Transl Med

Publisher AME Publishing Company

Date 2020 Feb 5

PMID 32016019

Citations 10

Authors

Alejandro Valencia-Rodriguez

Alfonso Vera-Barajas

Beatriz Barranco-Fragoso

Deyanira Kusulas-Delint

Xingshun Qi

Nahum Mendez-Sanchez

Affiliations

Soon will be listed here.

Citing Articles

Associations of Metabolic Dysfunction-Associated Fatty Liver Disease With Peripheral Artery Disease: Prospective Analysis in the UK Biobank and ARIC Study.

Liu Y, Wang J, Jin R, Xu Z, Zhao X, Li Y J Am Heart Assoc. 2024; 13(22):e035265.

PMID: 39547959 PMC: 11681420. DOI: 10.1161/JAHA.124.035265.

Anti-Inflammatory Oxysterol, Oxy210, Inhibits Atherosclerosis in Hyperlipidemic Mice and Inflammatory Responses of Vascular Cells.

Stappenbeck F, Wang F, Sinha S, Hui S, Farahi L, Mukhamedova N Cells. 2024; 13(19).

PMID: 39404395 PMC: 11475996. DOI: 10.3390/cells13191632.

When the liver is in poor condition, so is the heart - cardiac remodelling in MASH mouse models.

Bott S, Lallement J, Marino A, Daskalopoulos E, Beauloye C, Esfahani H Clin Sci (Lond). 2024; 138(18):1151-1171.

PMID: 39206703 PMC: 11405860. DOI: 10.1042/CS20240833.

From Liver to Brain: How MAFLD/MASLD Impacts Cognitive Function.

Medina-Julio D, Ramirez-Mejia M, Cordova-Gallardo J, Peniche-Luna E, Cantu-Brito C, Mendez-Sanchez N Med Sci Monit. 2024; 30:e943417.

PMID: 38282346 PMC: 10836032. DOI: 10.12659/MSM.943417.

Effect of atorvastatin on subclinical atherosclerosis in virally-suppressed HIV-infected patients with CMV seropositivity: a randomized double-blind placebo-controlled trial.

Yunihastuti E, Rusdi L, Azizi M, Estiasari R, Jasirwan C, Wulandari E F1000Res. 2023; 10:151.

PMID: 37772075 PMC: 10523096. DOI: 10.12688/f1000research.28262.2.

References

Shao D, Lian Z, Di Y, Zhang L, Rajoka M, Zhang Y . Dietary compounds have potential in controlling atherosclerosis by modulating macrophage cholesterol metabolism and inflammation via miRNA. NPJ Sci Food. 2019; 2:13. PMC: 6550192. DOI: 10.1038/s41538-018-0022-8. View

Brea A, Mosquera D, Martin E, Arizti A, Cordero J, Ros E . Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study. Arterioscler Thromb Vasc Biol. 2005; 25(5):1045-50. DOI: 10.1161/01.ATV.0000160613.57985.18. View

Wu R, Hou F, Wang X, Zhou Y, Sun K, Wang Y . Nonalcoholic Fatty Liver Disease and Coronary Artery Calcification in a Northern Chinese Population: a Cross Sectional Study. Sci Rep. 2017; 7(1):9933. PMC: 5577292. DOI: 10.1038/s41598-017-09851-5. View

Jaruvongvanich V, Wirunsawanya K, Sanguankeo A, Upala S . Nonalcoholic fatty liver disease is associated with coronary artery calcification: A systematic review and meta-analysis. Dig Liver Dis. 2016; 48(12):1410-1417. DOI: 10.1016/j.dld.2016.09.002. View

Gutierrez-Grobe Y, Gavilanes-Espinar J, Masso-Rojas F, Sanchez-Valle V, Paez-Arenas A, Ponciano-Rodriguez G . Metabolic syndrome and nonalcoholic fatty liver disease. The role of endothelial progenitor cells. Ann Hepatol. 2013; 12(6):908-14. View

Chiang C, Huang P, Chung F, Chen Z, Leu H, Huang C . Decreased circulating endothelial progenitor cell levels and function in patients with nonalcoholic fatty liver disease. PLoS One. 2012; 7(2):e31799. PMC: 3280999. DOI: 10.1371/journal.pone.0031799. View

Libby P, Buring J, Badimon L, Hansson G, Deanfield J, Bittencourt M . Atherosclerosis. Nat Rev Dis Primers. 2019; 5(1):56. DOI: 10.1038/s41572-019-0106-z. View

Targher G, Day C, Bonora E . Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med. 2010; 363(14):1341-50. DOI: 10.1056/NEJMra0912063. View

Wu S, Wu F, Ding Y, Hou J, Bi J, Zhang Z . Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: A systematic review and meta-analysis. Sci Rep. 2016; 6:33386. PMC: 5026028. DOI: 10.1038/srep33386. View

10.

Liu J, Musani S, Bidulescu A, Carr J, Wilson J, Taylor H . Fatty liver, abdominal adipose tissue and atherosclerotic calcification in African Americans: the Jackson Heart Study. Atherosclerosis. 2012; 224(2):521-5. PMC: 3459068. DOI: 10.1016/j.atherosclerosis.2012.07.042. View

11.

Targher G, Byrne C, Lonardo A, Zoppini G, Barbui C . Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis. J Hepatol. 2016; 65(3):589-600. DOI: 10.1016/j.jhep.2016.05.013. View

12.

Srivastava R . Life-style-induced metabolic derangement and epigenetic changes promote diabetes and oxidative stress leading to NASH and atherosclerosis severity. J Diabetes Metab Disord. 2019; 17(2):381-391. PMC: 6405391. DOI: 10.1007/s40200-018-0378-y. View

13.

Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A . Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med. 2005; 353(10):999-1007. DOI: 10.1056/NEJMoa043814. View

14.

Koo B, Allison M, Criqui M, Denenberg J, Wright C . The association between liver fat and systemic calcified atherosclerosis. J Vasc Surg. 2019; 71(1):204-211.e4. DOI: 10.1016/j.jvs.2019.03.044. View

15.

Mendez-Sanchez N, Cruz-Ramon V, Ramirez-Perez O, Hwang J, Barranco-Fragoso B, Cordova-Gallardo J . New Aspects of Lipotoxicity in Nonalcoholic Steatohepatitis. Int J Mol Sci. 2018; 19(7). PMC: 6073816. DOI: 10.3390/ijms19072034. View

16.

Mendez-Sanchez N, Chavez-Tapia N, Almeda-Valdes P, Uribe M . The management of incidental fatty liver found on imaging. What do we need to do?. Am J Gastroenterol. 2018; 113(9):1274-1276. DOI: 10.1038/s41395-018-0047-2. View

17.

Villanova N, Moscatiello S, Ramilli S, Bugianesi E, Magalotti D, Vanni E . Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology. 2005; 42(2):473-80. DOI: 10.1002/hep.20781. View

18.

Salvi P, Ruffini R, Agnoletti D, Magnani E, Pagliarani G, Comandini G . Increased arterial stiffness in nonalcoholic fatty liver disease: the Cardio-GOOSE study. J Hypertens. 2010; 28(8):1699-707. DOI: 10.1097/HJH.0b013e32833a7de6. View

19.

Mendez-Sanchez N, Zamora-Valdes D, Flores-Rangel J, Perez-Sosa J, Vasquez-Fernandez F, Lezama-Mora J . Gallstones are associated with carotid atherosclerosis. Liver Int. 2007; 28(3):402-6. DOI: 10.1111/j.1478-3231.2007.01632.x. View